U.S. FDA nominee moves to untangle potential conflicts of interest

March 29 (Reuters) - Dr. Scott Gottlieb, President Donald

Trump's nominee to lead the U.S. Food and Drug Administration,

has outlined measures he would take to untangle his ties to the

pharmaceutical industry if confirmed by the Senate.

Read more